News
43m
Korea JoongAng Daily on MSNKorea develops world's 1st recombinant anthrax vaccineKorea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...
3h
Yonhap News Agency on MSNS. Korea develops world's 1st recombinant anthrax vaccineSouth Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that could also open export markets for the new vaccine with fewer side ...
Peter Redweik’s brutal infection was quelled by a medication so powerful that doctors use it sparingly. Yet he continued to ...
The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...
The World Health Organization (WHO) actively responds to anthrax epidemic in the Democratic Republic of the Congo (DRC) ...
The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...
The county is responding to a potential anthrax outbreak in Gatanga Constituency, after over 600 residents ate meat from a ...
This month’s cover story, entitled “Dubious Treatments, ‘Snake Oil Salesmen’ Grab Attention in Rheumatology,” features a stellar lineup of discussants, including Adam Brown, MD; Allan ...
The launch of Qureight's Synthetic Study Arms is a watershed moment for clinical research in lung diseases. By creating an ethical, image-driven synthetic control arm, we can accelerate trial ...
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role as a key regulator in systemic inflammatory diseases, acting as a central mediator in the downstream signaling cascades of Toll ...
Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations in diagnosis and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results